Rxivist logo

Author: Ofir Cohen

  • Most recently observed institution: Broad Institute of MIT and Harvard

Rankings

  • All-time downloads: 9,774 (rank: 7,522 (tie) out of 365,919)
  • Categories:
    • cancer biology: 3,479 (rank: 675 out of 24,792)
    • genomics: 6,295 (rank: 2,500 (tie) out of 39,354)

Downloads per author, site-wide

Preprints

A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors

genomics more details view paper
  • Downloaded 6,295 times
  • Download rankings, all-time:
    • Site-wide: 474 out of 85,056
    • In genomics: 103 out of 5,478
  • Year to date:
    • Site-wide: 260 out of 85,056
  • Since beginning of last month:
    • Site-wide: 705 out of 85,056

Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer

cancer biology more details view paper
  • Downloaded 1,317 times
  • Download rankings, all-time:
    • Site-wide: 6,884 out of 85,056
    • In cancer biology: 185 out of 2,984
  • Year to date:
    • Site-wide: 5,805 out of 85,056
  • Since beginning of last month:
    • Site-wide: 5,499 out of 85,056

Opposing immune and genetic forces shape oncogenic programs in synovial sarcoma

cancer biology more details view paper
  • Downloaded 1,003 times
  • Download rankings, all-time:
    • Site-wide: 10,783 out of 85,056
    • In cancer biology: 308 out of 2,984
  • Year to date:
    • Site-wide: 4,604 out of 85,056
  • Since beginning of last month:
    • Site-wide: 5,589 out of 85,056

The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer

cancer biology more details view paper
  • Downloaded 796 times
  • Download rankings, all-time:
    • Site-wide: 15,396 out of 85,056
    • In cancer biology: 445 out of 2,984
  • Year to date:
    • Site-wide: 3,298 out of 85,056
  • Since beginning of last month:
    • Site-wide: 3,619 out of 85,056

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

cancer biology more details view paper
  • Downloaded 363 times
  • Download rankings, all-time:
    • Site-wide: 42,270 out of 85,056
    • In cancer biology: 1,329 out of 2,984
  • Year to date:
    • Site-wide: 19,617 out of 85,056
  • Since beginning of last month:
    • Site-wide: 20,361 out of 85,056

PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News